XENON PHARMACEUTICALS INC (XENE) Stock Cash Flow
NASDAQ:XENE - Nasdaq - CA98420N1050 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -199.06M | -234.33M | -182.39M | -125.37M | -78.88M | |||
| Depreciation Amortization | 3.84M | 2.56M | 2.06M | 1.62M | 910.00K | |||
| Income Taxes - Deferred | -282.00K | -8.86M | -292.00K | -40.00K | 60.00K | |||
| Change In Working Capital | 611.00K | 5.71M | 5.90M | -680.00K | -2.65M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 41.34M | 53.53M | 23.61M | 26.04M | 11.06M | |||
| OPERATING CASH FLOW | -153.55M | -181.39M | -151.11M | -98.43M | -69.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.98M | -3.08M | -5.62M | -2.89M | -2.05M | |||
| Other Investing Activity | -124.19M | 168.07M | -105.77M | -293.11M | -244.72M | |||
| INVESTING CASH FLOW | -127.17M | 165.00M | -111.39M | -296.00M | -246.77M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | N/A | 12.13M | 353.52M | 278.47M | 447.54M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | 12.13M | 353.52M | 278.47M | 447.54M | |||
| Exchange Rate Effect | -613.00K | -1.67M | 376.00K | -2.48M | -590.00K | |||
| CHANGE IN CASH | 72.18M | -5.93M | 91.40M | -118.44M | 130.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -153.55M | -181.39M | -151.11M | -98.43M | -69.50M | |||
| Capital Expenditure | -2.98M | -3.08M | -5.62M | -2.89M | -2.05M | |||
| FREE CASH FLOW | -156.53M | -184.46M | -156.73M | -101.32M | -71.55M | |||
All data in USD